Publishing in European Heart Journal: Fit, Timeline & Submission Guide

ESC registry data is a golden pathway

If you have access to ESC registry data or can contribute to ongoing ESC registries, this creates natural alignment with editorial priorities. Registry-based studies perform exceptionally well.

The ESC guideline connection is real

European Heart Journal papers often become the evidence base for ESC guidelines. If your research addresses guideline gaps or controversies, emphasize this potential impact.

Big numbers matter more than elegant mechanisms

A 50,000-patient registry study with modest effect sizes often trumps a 200-patient mechanistic study with dramatic findings. Scale and clinical relevance win over biological insights.

European authorship helps but isn't essential

Having European co-authors or European study sites strengthens submissions, but excellent research from other continents gets published if it has global relevance.

Cardiovascular imaging papers do particularly well

European Heart Journal has a strong tradition in cardiovascular imaging research. Novel imaging techniques, outcome predictions from imaging, or imaging-guided therapy studies get favorable review.

The rapid publication track exists for urgent findings

For time-sensitive cardiovascular research - safety signals, practice-changing results, pandemic-related findings - European Heart Journal offers expedited review and publication.

Population health and prevention are editorial priorities

Studies on cardiovascular disease prevention, population screening, or health system interventions align with ESC's public health mission and get serious consideration.

Heart failure research has particular prominence

Given the aging European population and heart failure epidemic, well-designed heart failure studies get prioritized. This includes device studies, drug trials, and care delivery research.